News & Media

Delhi HC stays ban on sale and manufacture of Oxytocin till October

Aug 31, 2018
  • Published by : Bar & Bench
  • Author(s) : Ashish Prasad
  • The Delhi High Court today stayed Central Government’s decision to ban the sale and manufacture of oxytocin, a peptide hormone, by private companies, till October 1.

    We are of the prima facie opinion that the domestic ban/complete prohibition on the sale and manufacturing of oxytocin should be suspended for one month. Parties may in the meantime complete their submissions. List for further arguments.”, the Court said.

    A Division Bench comprising Justices S Ravindra Bhat

    Related Articles

    News & Media

    Deal Updates: ELP advises on Acquisition of... 23 October 2018

    Deal reporting of Samara Capital Partners Fund II and...

    News & Media

    Are home buyers secured financial creditors or... 23 October 2018

    On June 6, the Insolvency and Bankruptcy Code, 2016 (IBC)...

    News & Media

    Delhivery co-founders lead seed in foodtech... 23 October 2018

    Ahmedabad based startup ‘FoodMemories’, a marketplace...

    News & Media

    Delhivery co-founders lead seed in foodtech... 23 October 2018

    Ahmedabad-based FoodMemories, a marketplace for authentic...